Abstract
Background: Intermittent inotropic infusions improve the clinical condition of patients with end-stage congestive heart failure (CHF). Brain natriuretic peptide (BNP) is a reliable prognostic factor for the survival of patients with CHF. The aim of the present study was to evaluate the probable prognostic value of changes in BNP regarding the outcome of patients treated with intermittent inotropic infusions. Methods: Fifteen patients with decompensated CHF refractory to standard medical treatment were treated with oral amiodarone and intermittent inotropic infusions for 8 hours every week for a period of 6 months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
